DE69906633D1 - Mischung bestehend aus ein Retinoid und eine Histidinederivate - Google Patents

Mischung bestehend aus ein Retinoid und eine Histidinederivate

Info

Publication number
DE69906633D1
DE69906633D1 DE69906633T DE69906633T DE69906633D1 DE 69906633 D1 DE69906633 D1 DE 69906633D1 DE 69906633 T DE69906633 T DE 69906633T DE 69906633 T DE69906633 T DE 69906633T DE 69906633 D1 DE69906633 D1 DE 69906633D1
Authority
DE
Germany
Prior art keywords
retinoid
mixture consisting
histidine derivative
histidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69906633T
Other languages
English (en)
Other versions
DE69906633T2 (de
Inventor
Boudiaf Boussouira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69906633D1 publication Critical patent/DE69906633D1/de
Application granted granted Critical
Publication of DE69906633T2 publication Critical patent/DE69906633T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69906633T 1998-05-26 1999-05-07 Kombination aus einem Retinoid und einem Histidinderivat Expired - Fee Related DE69906633T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806603 1998-05-26
FR9806603A FR2779060B1 (fr) 1998-05-26 1998-05-26 Association d'un retinoide avec un derive d'histidine

Publications (2)

Publication Number Publication Date
DE69906633D1 true DE69906633D1 (de) 2003-05-15
DE69906633T2 DE69906633T2 (de) 2004-03-25

Family

ID=9526710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906633T Expired - Fee Related DE69906633T2 (de) 1998-05-26 1999-05-07 Kombination aus einem Retinoid und einem Histidinderivat

Country Status (9)

Country Link
US (1) US6358514B1 (de)
EP (1) EP0972511B1 (de)
JP (1) JP3095741B2 (de)
KR (1) KR100332260B1 (de)
BR (1) BR9901955A (de)
CA (1) CA2272840A1 (de)
DE (1) DE69906633T2 (de)
ES (1) ES2196737T3 (de)
FR (1) FR2779060B1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
AU782821B2 (en) * 2000-01-19 2005-09-01 Geoffrey Walter Grigg Treatment of UV induced immunosuppression
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
FR2815252B1 (fr) * 2000-10-17 2002-12-20 Oreal Composition, notamment cosmetique, renfermant du retinol et un compose capable de filtrer le rayonnement uva
FR2815857B1 (fr) * 2000-10-30 2003-02-14 Oreal Composition, notamment cosmetique, renfermant un retinoide et une silicone benzotriazole
EP1388339A1 (de) * 2002-08-06 2004-02-11 Naina Sachdev Alkalisches Antifaltenmittel Carnosin enthaltend
MXPA05013032A (es) * 2003-06-04 2006-05-25 Ebersytes Llc Composicion dermatologica novedosa.
US20060120980A1 (en) * 2004-12-02 2006-06-08 Eberl James J Novel dermatological composition using bio-activating organocatalysts
DE102006042244A1 (de) 2006-09-06 2008-03-27 Henkel Kgaa Verfahren zur molekularen Charakterisierung von Altershaar
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929840A (en) * 1972-07-14 1975-12-30 Merck & Co Inc Labile esters of ({31 )(cis-1,2-epoxypropyl)phosphonic
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
US5126261A (en) * 1989-04-12 1992-06-30 Board Of Regents, The University Of Texas System High calcium chemically defined culture medium
DE69225631T2 (de) * 1991-02-19 1998-12-17 Nat Food Research Inst Ministr Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
US5441740A (en) * 1994-05-06 1995-08-15 Longevity Network. Ltd. Cosmetic composition containing alpha hydroxyacids, salicyclic acid, and enzyme mixture of bromelain and papain
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie

Also Published As

Publication number Publication date
FR2779060B1 (fr) 2003-05-02
EP0972511A1 (de) 2000-01-19
JP2000007560A (ja) 2000-01-11
EP0972511B1 (de) 2003-04-09
ES2196737T3 (es) 2003-12-16
US6358514B1 (en) 2002-03-19
BR9901955A (pt) 2000-06-06
CA2272840A1 (fr) 1999-11-26
DE69906633T2 (de) 2004-03-25
FR2779060A1 (fr) 1999-12-03
KR19990088439A (ko) 1999-12-27
JP3095741B2 (ja) 2000-10-10
KR100332260B1 (ko) 2002-04-12

Similar Documents

Publication Publication Date Title
ATE252832T1 (de) Kombinationen aus herbiziden und safenern
BR9500784A (pt) Composto e formulação farmacêutica
PT1127052E (pt) 2-fenilbenzimidazois substituidos sua preparacao e aplicacao
DE69904208T2 (de) Antioxidative mischung bestehend aus acetyl l-carnitin und alpha-liponsäure
ATA69098A (de) Stoffgemisch zur topischen anwendung
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
DE69842004D1 (de) Substituierte 2-aminoacetamide und anwendung davon
DE69838849D1 (de) Mehrchipmodulstruktur und seine herstellung
DE69826975D1 (de) Thermoelektrisches element und herstellungsverfahren dafür
DE69831999D1 (de) Magnetkopf und Herstellungsverfahren
DE69909247D1 (de) Mischungen aus thermoplastischen fluorpolymeren
DK0702344T3 (da) Etiketkontinuum og fremgangsmåde til fremstilling deraf
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
DE69714067T2 (de) Zusammensetzungen aus fluorkohlenwasserstoffen
DE69826008D1 (de) Mischungen aus polyimiden und elastomeren
DE69906633D1 (de) Mischung bestehend aus ein Retinoid und eine Histidinederivate
DK1003383T3 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
BR9507371A (pt) Derivado de benzamida composições contendo o dito derivado e uso do mesmo
DE69506578D1 (de) Additive und ölhaltige mischungen
DE69804285D1 (de) Esterverbindung und diese enthaltendes Schädlingsbekämpfungsmittel
BR9509688A (pt) Composto e composição farmacêutica
DE69718077D1 (de) Arzneimittel bestehend aus Diclofenac
DE59804730D1 (de) Siebelement und Verfahren zu siener Herstellung
DE69934134D1 (de) Mischungen aus trisilylierten kieselsäuren und alkylpolysiloxanen
DE69927585D1 (de) Alpha-hydroxy fettsäurenderivate und zubereitungen zur äusserlichen anwendung diese enthaltend

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee